Gloucestershire Oncology Centre at Cheltenham General Hospital
Cheltenham, England, United Kingdom
Hospital department in Cheltenham, England
Cheltenham General Hospital, Sandford Rd, Cheltenham GL53 7AN
About Gloucestershire Oncology Centre at Cheltenham General Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Gloucestershire Oncology Centre at Cheltenham General Hospital
During the past decade, Gloucestershire Oncology Centre at Cheltenham General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
2001-03-01
2008-11-01
Completed
S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
2006-04-01
Unknown status
500
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
2005-07-01
2021-12-13
Completed
6,927
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
2013-07-01
2014-06-01
Terminated
18
Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
2014-01-01
2019-12-01
Completed
310
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gloucestershire Oncology Centre at Cheltenham General Hospital" #1 sponsor was "Medical Research Council" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "University College, London" with 3 trials sponsored, "Wales Cancer Trials Unit" with 2 trials sponsored and "Cancer Research UK"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gloucestershire Oncology Centre at Cheltenham General Hospital"
#1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Velindre NHS Trust" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Gloucestershire Oncology Centre at Cheltenham General Hospital
According to Clinical.Site data, the most researched conditions in "Gloucestershire Oncology Centre at Cheltenham General Hospital" are
"Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Lymphoma" (3 trials), "Metastatic Cancer" (3 trials) and "Ovarian Cancer" (3 trials). Many other conditions were trialed in "Gloucestershire Oncology Centre at Cheltenham General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Gloucestershire Oncology Centre at Cheltenham General Hospital
Most popular intervention types in "Gloucestershire Oncology Centre at Cheltenham General Hospital" are "Drug" (22 trials), "Procedure" (11 trials), "Biological" (8 trials), "Other" (6 trials) and "Genetic" (3 trials). Other intervention types were less common.
The name of intervention was led by "quality-of-life assessment" (6 trials), "cisplatin" (5 trials), "carboplatin" (4 trials), "Cyclophosphamide" (3 trials) and "adjuvant therapy" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Gloucestershire Oncology Centre at Cheltenham General Hospital
The vast majority of trials in "Gloucestershire Oncology Centre at Cheltenham General Hospital" are
18 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Gloucestershire Oncology Centre at Cheltenham General Hospital
Currently, there are NaN active trials in "Gloucestershire Oncology Centre at Cheltenham General Hospital".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in Gloucestershire Oncology Centre at Cheltenham General Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Gloucestershire Oncology Centre at Cheltenham General Hospital, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".